China Resources Double Crane: clinical trial DC05F01 was approved

2022-06-09 0 By

Financial Union on April 6, China Resources Double Crane announcement, received the state Food and Drug Administration issued DC05F01 “drug clinical trial approval notice”, approved the drug to carry out a single drug in solid tumor patients in the clinical trial.